High Pointe Capital Management’s Merck MRK Stock Holding History

High Pointe Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,419	Closed	-$916K	–	85
2020 Q2	$916K	Buy	+12,419	New	+$935K	1.2%	33
2017 Q1	–	Sell	-20,132	Closed	-$1.13M	–	82
2016 Q4	$1.13M	Sell	20,132 -419	-2%	-$24.5K	1.86%	20
2016 Q3	$1.22M	Sell	20,551 -9,327	-31%	-$545K	2.17%	15
2016 Q2	$1.64M	Sell	29,878 -2,254	-7%	-$120K	2.5%	9
2016 Q1	$1.62M	Hold	32,132	–	–	2.35%	14
2015 Q4	$1.62M	Buy	+32,132	New	+$1.62M	0.79%	39
2014 Q2	–	Sell	-5,764	Closed	-$312K	–	167
2014 Q1	$312K	Sell	5,764 -2,306	-29%	-$119K	0.12%	138
2013 Q4	$385K	Sell	8,070 -5,921	-42%	-$271K	0.15%	135
2013 Q3	$636K	Buy	13,991 +105	+0.8%	+$4.79K	0.26%	108
2013 Q2	$615K	Buy	+13,886	New	+$620K	0.27%	106

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

High Pointe Capital Management's MRK Position: Q3 2020 in Review

High Pointe Capital Management sold out of Merck (MRK) in Q3 2020, closing a stake of 12,419 shares — an estimated $916K sold.

High Pointe Capital Management first reported a position in MRK in Q2 2013 and held it in 10 quarters. The position peaked at $1.64M in Q2 2016. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

High Pointe Capital Management reported no remaining Merck position as of Q3 2020 after selling out during the quarter.
High Pointe Capital Management sold 12,419 Merck shares in Q3 2020, an estimated $916K.
High Pointe Capital Management first reported a position in Merck in Q2 2013 and held it in 10 quarters.
High Pointe Capital Management's Merck position peaked at $1.64M in Q2 2016.
2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on High Pointe Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.